{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Valsartan+320+mg&page=2", "query": { "intervention": "Valsartan 320 mg", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 30, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Valsartan+320+mg&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Valsartan+320+mg&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T23:41:20.380Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01281306", "title": "An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Systolic Hypertension" ], "interventions": [ { "name": "LCZ696", "type": "DRUG" }, { "name": "Valsartan", "type": "DRUG" }, { "name": "AHU377", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 910, "start_date": "2011-01", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2016-01-29", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 19, "location_summary": "Clearwater, Florida • Chicago, Illinois • Metairie, Louisiana + 12 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Metairie", "state": "Louisiana" }, { "city": "Belzoni", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT01281306" }, { "nct_id": "NCT00657241", "title": "Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Carvedilol CR", "type": "DRUG" }, { "name": "Valsartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "State University of New York at Buffalo", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2008-04", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2022-05-27", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00657241" }, { "nct_id": "NCT00439738", "title": "Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "HCTZ + Amlodipine", "type": "DRUG" }, { "name": "Valsartan/HCTZ", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 412, "start_date": "2006-12", "completion_date": null, "has_results": true, "last_update_posted_date": "2017-05-16", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 5, "location_summary": "Muscle Shoals, Alabama • Westlake Village, California • Oklahoma City, Oklahoma + 2 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Westlake Village", "state": "California" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Euless", "state": "Texas" }, { "city": "Port Orchard", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00439738" }, { "nct_id": "NCT01415505", "title": "Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Nebivolol, Valsartan and Hydrochlorothiazide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 812, "start_date": "2011-08", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2013-06-04", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 135, "location_summary": "Birmingham, Alabama • Foley, Alabama • Gulf Shores, Alabama + 113 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Foley", "state": "Alabama" }, { "city": "Gulf Shores", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01415505" }, { "nct_id": "NCT00409643", "title": "Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "valsartan+amlodipine combination", "type": "DRUG" }, { "name": "valsartan", "type": "DRUG" }, { "name": "amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1259, "start_date": "2004-01", "completion_date": "2004-07", "has_results": false, "last_update_posted_date": "2011-11-08", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00409643" }, { "nct_id": "NCT03686657", "title": "Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Type 2 Diabetes", "High Blood Pressure", "Arthritis", "Obesity" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Val, Cel and Met XR Low", "type": "DRUG" }, { "name": "Val, Cel and Met XR High", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ARKAY Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2026-12-10", "completion_date": "2031-01-31", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 1, "location_summary": "Albany, New York", "locations": [ { "city": "Albany", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03686657" }, { "nct_id": "NCT05056727", "title": "A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Renal Insufficiency, Chronic", "Hyperkalemia" ], "interventions": [ { "name": "Sodium Zirconium Cyclosilicate (SZC)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Lisinopril", "type": "DRUG" }, { "name": "Valsartan", "type": "DRUG" }, { "name": "Irbesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 1112, "start_date": "2021-09-30", "completion_date": "2024-02-07", "has_results": true, "last_update_posted_date": "2026-01-08", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 42, "location_summary": "Surprise, Arizona • Tucson, Arizona • Canyon Country, California + 36 more", "locations": [ { "city": "Surprise", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Canyon Country", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05056727" }, { "nct_id": "NCT00170937", "title": "A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "METABOLIC SYNDROME", "HYPERTENSION", "PRE-HYPERTENSION" ], "interventions": [ { "name": "valsartan plus hydrochlorothiazide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 507, "start_date": "2004-11", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-11-18", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00170937" }, { "nct_id": "NCT00433836", "title": "Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Valsartan", "type": "DRUG" }, { "name": "Enalapril", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 300, "start_date": "2007-01", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2011-05-19", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00433836" }, { "nct_id": "NCT00696436", "title": "An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Azilsartan medoxomil", "type": "DRUG" }, { "name": "Valsartan", "type": "DRUG" }, { "name": "Olmesartan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1291, "start_date": "2008-04", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2011-04-19", "last_synced_at": "2026-10-04T23:41:20.380Z", "location_count": 86, "location_summary": "Alabaster, Alabama • Ozark, Alabama • Green Valley, Arizona + 83 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Ozark", "state": "Alabama" }, { "city": "Green Valley", "state": "Arizona" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00696436" } ] }